(Q45109090)

9 December 2017

title

Asthma: benchmarking for quality improvement (English)

1 reference

9 December 2017

1 reference

Stempel DA

1

1 reference

9 December 2017

Carlson AM

series ordinal

2

1 reference

9 December 2017

Buchner DA

series ordinal

3

1 reference

9 December 2017

publication date

1 December 1997

1 reference

Annals of Allergy, Asthma & Immunology

9 December 2017

published in

1 reference

9 December 2017

volume

79

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

517-524

1 reference

Randomised comparison of guided self management and traditional treatment of asthma over one year

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

The cost and effectiveness of an education program for adults who have asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

An economic evaluation of asthma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963059-1

7 January 2021

10.1016/S1081-1206(10)63059-1

Identifiers

DOI

1 reference

9 December 2017

1 reference